Literature DB >> 24900884

Late-Stage C-H Coupling Enables Rapid Identification of HDAC Inhibitors: Synthesis and Evaluation of NCH-31 Analogues.

Hiromi Sekizawa1, Kazuma Amaike1, Yukihiro Itoh2, Takayoshi Suzuki3, Kenichiro Itami4, Junichiro Yamaguchi1.   

Abstract

We previously reported the discovery of NCH-31, a potent histone deacetylase (HDAC) inhibitor. By utilizing our C-H coupling reaction, we rapidly synthesized 16 analogues (IYS-1 through IYS-15 and IYS-Me) of NCH-31 with different aryl groups at the C4-position of 2-aminothiazole core of NCH-31. Subsequent biological testing of these derivatives revealed that 3-fluorophenyl (IYS-10) and 4-fluorophenyl (IYS-15) derivatives act as potent pan-HDAC inhibitor. Additionally, 4-methylphenyl (IYS-1) and 3-fluoro-4-methylphenyl (IYS-14) derivatives acted as HDAC6-insensitive inhibitors. The present work clearly shows the power of the late-stage C-H coupling approach to rapidly identify novel and highly active/selective biofunctional molecules.

Entities:  

Keywords:  C−H coupling; HDAC6; Histone deacetylase; inhibitor

Year:  2014        PMID: 24900884      PMCID: PMC4027735          DOI: 10.1021/ml500024s

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  22 in total

Review 1.  Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.

Authors:  Christina M Grozinger; Stuart L Schreiber
Journal:  Chem Biol       Date:  2002-01

Review 2.  Isoform-selective histone deacetylase inhibitors.

Authors:  Yukihiro Itoh; Takayoshi Suzuki; Naoki Miyata
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 3.  Histone deacetylase inhibitors: from bench to clinic.

Authors:  Marielle Paris; Marina Porcelloni; Monica Binaschi; Daniela Fattori
Journal:  J Med Chem       Date:  2008-02-05       Impact factor: 7.446

4.  Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.

Authors:  Takayoshi Suzuki; Yuki Nagano; Akiyasu Kouketsu; Azusa Matsuura; Sakiko Maruyama; Mineko Kurotaki; Hidehiko Nakagawa; Naoki Miyata
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

Review 5.  Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.

Authors:  Paul A Marks; Ronald Breslow
Journal:  Nat Biotechnol       Date:  2007-01       Impact factor: 54.908

Review 6.  Romidepsin: a novel histone deacetylase inhibitor for cancer.

Authors:  Erin M Bertino; Gregory A Otterson
Journal:  Expert Opin Investig Drugs       Date:  2011-06-24       Impact factor: 6.206

7.  Structural biasing elements for in-cell histone deacetylase paralog selectivity.

Authors:  Jason C Wong; Roger Hong; Stuart L Schreiber
Journal:  J Am Chem Soc       Date:  2003-05-14       Impact factor: 15.419

Review 8.  C-H bond functionalization: emerging synthetic tools for natural products and pharmaceuticals.

Authors:  Junichiro Yamaguchi; Atsushi D Yamaguchi; Kenichiro Itami
Journal:  Angew Chem Int Ed Engl       Date:  2012-08-06       Impact factor: 15.336

9.  Pd-catalyzed direct C-H bond functionalization of spirocyclic σ1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the σ1 receptor.

Authors:  Christina Meyer; Dirk Schepmann; Shuichi Yanagisawa; Junichiro Yamaguchi; Valentina Dal Col; Erik Laurini; Kenichiro Itami; Sabrina Pricl; Bernhard Wünsch
Journal:  J Med Chem       Date:  2012-09-10       Impact factor: 7.446

10.  Pd(II)-catalyzed cross-coupling of sp3 C-H Bonds with sp2 and sp3 boronic acids using air as the oxidant.

Authors:  Dong-Hui Wang; Masayuki Wasa; Ramesh Giri; Jin-Quan Yu
Journal:  J Am Chem Soc       Date:  2008-05-14       Impact factor: 15.419

View more
  1 in total

1.  Identification of α-Synuclein Proaggregator: Rapid Synthesis and Streamlining RT-QuIC Assays in Parkinson's Disease.

Authors:  Fumito Takada; Takahito Kasahara; Kentaro Otake; Takamitsu Maru; Masanori Miwa; Kei Muto; Minoru Sasaki; Yoshihiko Hirozane; Masato Yoshikawa; Junichiro Yamaguchi
Journal:  ACS Med Chem Lett       Date:  2022-08-11       Impact factor: 4.632

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.